
Join us for an informal time to connect with other patients living with IgA Nephropathy on the first Tuesday of each month at 8 p.m. ET. These support groups are moderated by NephCure patient support volunteers and/or NephCure staff.
The FDA has approved Gazyva® (Obinutuzumab) for Primary Membranous Nephropathy (pMN). Click here for more information. Please visit our Patient Navigation tool for support.

Join us for an informal time to connect with other patients living with IgA Nephropathy on the first Tuesday of each month at 8 p.m. ET. These support groups are moderated by NephCure patient support volunteers and/or NephCure staff.
Thank you to our generous sponsors for supporting NephCure Community Days!